Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden
Condition(s):Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)Last Updated:March 1, 2024Terminated